|
1. Guide to the diagnosis and treatment of Covid-19 at the levels of providing outpatient and inpatient services. 12th. 2023 Ministry of Health, Treatment and Medical Education. 2. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. Jama. 2020; 323(18): 1843-4 doi:10.1001/jama.2020.3786 PMid:32159775 PMCid:PMC7066521 3. Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis. 2020; 96: 467-474 doi:10.1016/j.ijid.2020.05.055 PMid:32425643 PMCid:PMC7233226 4. Ghahramani S, Tabrizi R, Lankarani KB, Kashani SMA, Rezaei S, Zeidi N, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020; 25(1):30. doi:10.1186/s40001-020-00432-3 PMid:32746929 PMCid:PMC7396942 5. Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One 2020; 15(8): e0238160. doi:10.1371/journal.pone.0238160, PMid:32822430 PMCid:PMC7446892 6. Ji P, Zhu J, Zhong Z, Li H, Pang J, Li B, Zhang J. Association of elevated inflammatory markers and severe COVID-19: A meta-analysis. Medicine (Baltimore). 2020;99(47):e23315. doi:10.1097/MD.0000000000023315 PMid:33217868 PMCid:PMC7676531 7. Izcovich A, Ragusa MA, Tortosa F, Marzio MAL, Agnoletti C, Bengolea A, et al. PLoS One. 2022 17(5): e0269291. doi:10.1371/journal.pone.0269291 PMid:35617192 PMCid:PMC9135219 8. Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J. 2021;42(23):2270-9 doi:10.1093/eurheartj/ehaa1103, PMid:33448289 PMCid:PMC7928982 9. Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020;92(7):856-62 doi:10.1002/jmv.25871 PMid:32281668 PMCid:PMC7262341 10. Pathak A, Agrawal A. Evolution of C-Reactive Protein. Front Immunol. 2019;10:943. doi:10.3389/fimmu.2019.00943, PMid:31114584 PMCid:PMC6503050 11. Lapić I, Rogić D, Plebani M. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis. Clin Chem Lab Med. 2020;58(7):1146-1148. doi:10.1515/cclm-2020-0620, PMid:32386190 12. Bao J, Li C, Zhang K, Kang H, Chen W, Gu B. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta. 2020;509:180-94. doi:10.1016/j.cca.2020.06.009, PMid:32511971 PMCid:PMC7274996 13. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-41 doi:10.1111/all.14238, PMid:32077115 14. Wang G, Wu C, Zhang Q, Wu F, Yu B, Lv J, et al. C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation. Open Forum Infect Dis. 2020;7(5):153. doi:10.1093/ofid/ofaa153, PMid:32455147 PMCid:PMC7197542 15. Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, Ebrahimpour S, Babazadeh A, Mehraeen R, et al. C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients. Interdiscip Perspect Infect Dis. 2021; 2021: 5557582. doi:10.1155/2021/5557582, PMid:33968148 PMCid:PMC8083820 16. Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020; 19(1): 18. doi:10.1186/s12941-020-00362-2 PMid:32414383 PMCid:PMC7227180 17. Lapić I, Rogić D, Plebani M. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis. Clin Chem Lab Med. 2020; 58(7):1146-1148. doi:10.1515/cclm-2020-0620 PMid:32386190
|
_-_Copy.png)
.png){kind=logo}
